Jacopo Mariotti

11PUBLICATIONS
13CO-AUTHORS
Transplantation immunologyEpidemiological modellingHaematologyRespiratory diseasesMedical virology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Sep 01, 2025
Reduced incidence of relapse after checkpoint inhibitors relative to brentuximab vedotin as salvage therapy before allogeneic stem cell transplantation for refractory/relapsed Hodgkin lymphoma: A retrospective analysis.

Jacopo Mariotti, Chiara Pinton, Laura Giordano

|Nov 22, 2022
EASIX predicts non-relapse mortality after haploidentical transplantation with post-transplant cyclophosphamide.

Jacopo Mariotti, Filippo Magri, Laura Giordano

|Jul 15, 2021
Cytokine release syndrome after haploidentical hematopoietic cell transplantation: an international multicenter analysis.

Ramzi Abboud, Fei Wan, Jacopo Mariotti

|Nov 09, 2019
Pretransplant active disease status and HLA class II mismatching are associated with increased incidence and severity of cytokine release syndrome after haploidentical transplantation with posttransplant cyclophosphamide.

Jacopo Mariotti, Daniela Taurino, Fabrizio Marino

|Mar 21, 2019
Peripheral blood stem cell for haploidentical transplantation with post-transplant high dose cyclophosphamide: detailed analysis of 181 consecutive patients.

Angela Granata, Sabine Fürst, Stefania Bramanti

|Jan 26, 2019
The new refined minnesota risk score for acute graft-versus-host disease predicts overall survival and non-relapse mortality after T cell-replete haploidentical stem cell transplant with post-transplant cyclophosphamide.

Jacopo Mariotti, Angela Granata, Stefania Bramanti

Pageof 2

Frequent Collaborators

3 joint publications

Chiara De Philippis

2 joint publications

Luca Castagna

2 joint publications

Christian Chabannon

2 joint publications

Didier Blaise